Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Morphine antibody (Biotin)

The Mouse Monoclonal anti-Morphine antibody has been validated for ELISA. It is suitable to detect Morphine in samples from .
Catalog No. ABIN723278

Quick Overview for Morphine antibody (Biotin) (ABIN723278)

Target

Morphine

Reactivity

Please inquire

Host

  • 26
  • 5
  • 2
  • 1
Mouse

Clonality

  • 26
  • 8
Monoclonal

Conjugate

  • 16
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Morphine antibody is conjugated to Biotin

Application

  • 19
  • 10
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA

Clone

2F11
  • Cross-Reactivity (Details)

    Morphine

    Purification

    Purified by Protein G.

    Immunogen

    KLH conjugated Morphine molecular modified

    Isotype

    IgG
  • Application Notes

    ELISA 1:500-1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    Store at -20°C for 12 months.

    Expiry Date

    12 months
  • Target

    Morphine

    Target Type

    Chemical

    Background

    Synonyms: Morphine 6.

    Background: Morphine is thought to produce reinforcement phenomena via stimulation of mu, delta, and kappa opioid receptors that regulate stress perception, pain control, reward behavior, and neurohormone secretion in reward-relevant brain systems. It has the highest affinity for mu, followed by delta and kappa. Rapid activation of the mu opioid receptor by morphine results in a euphoric phenotype, thus conferring the reinforcing effects of the drug. This activation is accompanied by extracellular dopamine release, which alters several events related to the cAMP signal transduction pathway. Of particular significance is that CREB seems to be modified by morphine, thereby affecting addictive behavioral phenomena, such as withdrawal symptoms.

You are here:
Chat with us!